Gemigliptin placebo

DRUG3 trials

Sponsors

LG Life Sciences, LG Chem

Conditions

Diabetes Mellitus, Type 2T2DMType 2 Diabetes Mellitus

Phase 3

Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin

CompletedNCT01990469

LG Life SciencesT2DM

Start: 2014-01-31End: 2015-04-30Updated: 2016-04-19

Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)

CompletedNCT02831361

LG Life SciencesType 2 Diabetes Mellitus

Start: 2016-10-17End: 2018-02-08Updated: 2018-02-22

A Study to Evaluate the Efficacy and Safety of Gemigliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Dapagliflozin and Metformin (SOLUTION Study)

CompletedNCT03842267

LG ChemDiabetes Mellitus, Type 2

Start: 2019-05-13End: 2022-11-30Updated: 2023-03-10